Kanvas Biosciences Raises $48M to Advance Spatial Biology Platform and Immuno-Oncology Trials
What You Ought to Know Kanvas Biosciences has raised $48M in Collection A funding co-led by DCVC and Lions Capital LLC, bringing complete funding to $78M. The capital will fund medical trials for KAN-001, an immuno-oncology drug candidate designed for most cancers sufferers who don’t reply to immune checkpoint inhibitors (ICIs). The corporate makes use […]









